WHITEHAWK THERAPEUTICS, INC. Increase (Decrease) in Other Accrued Liabilities
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Increase (Decrease) in Other Accrued Liabilities of -$4.00 thousand for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccruedLiabilities · last filed 2012-05-15
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in other accrued liabilities for the quarter ending 2012-03-31 was -$4.00K.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in other accrued liabilities for the quarter ending 2011-03-31 was -$1.01K.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in other accrued liabilities for fiscal 2011 was $0.00.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in other accrued liabilities for fiscal 2010 was $0.00.
| Period end | Increase (Decrease) in Other Accrued Liabilities 3 month | Increase (Decrease) in Other Accrued Liabilities 12 month | Increase (Decrease) in Other Accrued Liabilities 49 month | Increase (Decrease) in Other Accrued Liabilities 52 month |
|---|---|---|---|---|
| 2012-03-31 | -$4.00K 10-Q · filed 2012-05-15 | $1.50K 10-Q · filed 2012-05-15 | ||
| 2011-12-31 | $0.00 10-K · filed 2012-03-30 | $5.50K 10-K · filed 2012-03-30 | ||
| 2011-03-31 | -$1.01K 10-Q · filed 2012-05-15 | |||
| 2010-12-31 | $0.00 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |